Faculty profile

Robert Inman

ResearcherMedicineUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.

Robert Inman

Researcher

Medicine

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
4 publications in the last five years, latest in 2026.
Principal investigator on 11 research grants (11 CIHR), most recently in 2025.
Supervisor on 1 trainee award (1 CIHR), most recently in 2009.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Ankylosing Spondylitis Arthritis T Cells Inflammation Adaptive Trials Biostatistics Clinical Trials Hqp Development

Latest papers

Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada Living Treatment Recommendations for the Management of Axial Spondyloarthritis: Update #1
Journal of Rheumatology · 2026
Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada Living Treatment Recommendations for the Management of Axial Spondyloarthritis
Journal of Rheumatology · 2025
Selective disruption of Traf1/cIAP2 interaction attenuates inflammatory responses and rheumatoid arthritis.
Journal of autoimmunity · 2025

All 9 publications

Latest funding

Targeting Exosome-Induced Regulatory T Cell Dysfunction in Ankylosing Spondylitis: A Preclinical Path to Precision Therapy
CIHR · 2025 · Nominated PI
$100,000
Dysregulation of Cytotoxic T Cell Exhaustion in Ankylosing Spondylitis
CIHR · 2023 · Nominated PI
$426,870
Canadian Training Platform for Trials Leveraging Existing Networks (CAN-TAP-TALENT)
CIHR · 2022 · Principal investigator
$4,314,242

All 16 grants and awards

9 publications.

Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada Living Treatment Recommendations for the Management of Axial Spondyloarthritis: Update #1

Richard N, Pardo JP, Mirza R, Aydin SZ, Bessette L, Mosher D, Boyd T, Chan J, Eder L, Passalent L

Journal of Rheumatology2026

DOI: 10.3899/jrheum.2026-0227

Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada Living Treatment Recommendations for the Management of Axial Spondyloarthritis

Rohekar S, Pardo JP, Mirza R, Aydin SZ, Bessette L, Richard N, Mosher D, Boyd T, Chan J, Eder L

Journal of Rheumatology20259 citations

DOI: 10.3899/jrheum.2023-1237

Selective disruption of Traf1/cIAP2 interaction attenuates inflammatory responses and rheumatoid arthritis.

Tang Y, Aleithan F, Madahar SS, Mirzaesmaeili A, Saran S, Tang J, Zangiabadi S, Inman R, Sweeney G, Abdul-Sater AA

Journal of autoimmunity2025

DOI: 10.1016/j.jaut.2025.103377 PMID: 39913998

Resilience is associated with cortical gray matter of the antinociceptive pathway in people with chronic pain.

Hector MS, Cheng JC, Hemington KS, Rogachov A, Kim JA, Osborne NR, Bosma RL, Fauchon C, Ayoub LJ, Inman R, Oh J, Anastakis DJ, Davis KD

Biological psychology2023

DOI: 10.1016/j.biopsycho.2023.108658 PMID: 37567549

Translating Improvements with Ixekizumab in Clinical Trial Outcomes into Clinical Practice: ASAS40, Pain, Fatigue, and Sleep in Ankylosing Spondylitis.

Mease P, Walsh JA, Baraliakos X, Inman R, de Vlam K, Wei JC, Hunter T, Gallo G, Sandoval D, Zhao F, Dong Y, Bolce R, Marzo-Ortega H

Rheumatology and therapy2019

DOI: 10.1007/s40744-019-0165-3 PMID: 31254223

Axial disease in psoriatic arthritis and ankylosing spondylitis: a critical comparison.

Feld J, Chandran V, Haroon N, Inman R, Gladman D

Nature reviews. Rheumatology2018

DOI: 10.1038/s41584-018-0006-8 PMID: 29752461

Infection with the Lyme disease pathogen suppresses innate immunity in mice with diet-induced obesity.

Zlotnikov N, Javid A, Ahmed M, Eshghi A, Tang TT, Arya A, Bansal A, Matar F, Parikh M, Ebady R, Koh A, Gupta N, Song P, Zhang Y, Newbigging S, Wormser GP, Schwartz I, Inman R, Glogauer M, Moriarty TJ

Cellular microbiology2017

DOI: 10.1111/cmi.12689 PMID: 27794208

Private rare deletions in SEC16A and MAMDC4 may represent novel pathogenic variants in familial axial spondyloarthritis.

O'Rielly DD, Uddin M, Codner D, Hayley M, Zhou J, Pena-Castillo L, Mostafa AA, Hasan SM, Liu W, Haroon N, Inman R, Rahman P

Annals of the rheumatic diseases2016

DOI: 10.1136/annrheumdis-2014-206484 PMID: 25956157

Contribution of phosphatidylserine to membrane surface charge and protein targeting during phagosome maturation.

Yeung T, Heit B, Dubuisson JF, Fairn GD, Chiu B, Inman R, Kapus A, Swanson M, Grinstein S

The Journal of cell biology2009

DOI: 10.1083/jcb.200903020 PMID: 19487458

Targeting Exosome-Induced Regulatory T Cell Dysfunction in Ankylosing Spondylitis: A Preclinical Path to Precision Therapy

Nominated PICIHR2025Project Grant - PA: Institute of Musculoskeletal Health and Arthritis: Pain

Principal investigators: Inman, Robert D

Keywords: Ankylosing Spondylitis; Arthritis; Inflammation

$100,000

Dysregulation of Cytotoxic T Cell Exhaustion in Ankylosing Spondylitis

Nominated PICIHR2023Project Grant

Principal investigators: Inman, Robert D

Keywords: Ankylosing Spondylitis; Arthritis; Immunology; T Cells

$426,870

Canadian Training Platform for Trials Leveraging Existing Networks (CAN-TAP-TALENT)

Principal investigatorCIHR2022Training Grant: Clinical Trials Training Platforms

Principal investigators: Cheung, Angela M; Ahmed, Sofia B; Allen, Upton D; Bhat, Mamatha; Boyd, Steven K; Crawley, Angela M; Dolatabadi, Elham; Fahim, Christine; Farkouh, Michael E; Feld, Jordan J; Fox, Susan; Furlan, Andrea D; Goligher, Ewan C; Hodgson, David C; Inman, Robert D; Juando Prats, Clara; Lamontagne, Francois; Langlois, Marc-Andre; Levin, Adeera; Mansfield, Avril; Manske, Sarah L; McMaster, W. Robert; Mylopoulos, Maria; Oza, Amit M; Papaioannou, Alexandra; Pinto, Andrew D; Quinn, Kieran L; Rahman, Proton; Razak, Fahad; Richard, Nicolas; Richardson, Harriet; Sander, Beate H; Sellmann, Susanna; Stelfox, Henry T; Straus, Sharon E; Tartaglia, Maria Carmela; Tobe, Sheldon W; Tomlinson, George A; Verma, Amol; Walmsley, Sharon L; Wu, Robert; Xu, Wei

Keywords: Adaptive Trials; Biostatistics; Clinical Trials; Hqp Development; Job Shadowing; Mentorship; Pedogagy; Training

$4,314,242

Canadian Training Platform for Trials Leveraging Existing Networks (CAN-TAP-TALENT)

Principal investigatorCIHR2022Training Grant: Clinical Trials Training Platforms - Indirect Costs

Keywords: Adaptive Trials; Biostatistics; Clinical Trials; Hqp Development; Job Shadowing; Mentorship; Pedogagy; Training

$1,078,562

Immune response after COVID-19 vaccination during maintenance therapy in immune-mediated inflammatory diseases: an observational cohort study (IMPACT)

Co-investigatorCIHR2021Operating Grant: Emerging COVID-19 Research Gaps and Priorities - Vaccines

Principal investigators: Chandran, Vinod

Keywords: Antibody Response; Covid-19; Immune-Mediated Inflammatory Diseases; Immunosuppression; T Cell Response; Vaccination; Variants Of Concern

T cell trafficking and specificity in ankylosing spondylitis

Nominated PICIHR2018Project Grant

Principal investigators: Inman, Robert D

Keywords: Ankylosing Spondylitis; Arthritis; Cell Trafficking; Mhc; T Cells

$745,876

Human Immunology Spondyloarthritis Team (HUMISPOT) studying immunopathogenesis, disease heterogeneity and drug discovery in spondyloarthritis

Principal investigatorCIHR2018Team Grant: Human Immunology Initiative: Research Teams - LOI

Principal investigators: Haroon, Nigil; Wither, Joan E; Allard-Chamard, Hugues; Chandran, Vinod; Crome, Sarah A; Gladman, Dafna D; Inman, Robert D; Jurisica, Igor; Rahman, Proton

Keywords: Antibody; Immunoassay; Sequencing; Spondyloarthritis; T Cells; T Regulatory Cells

$20,000

The Canadian-Netherlands Spondyloarthritis Network (CaN SpAN) for Improved Outcomes through Personalized Medicine

Nominated PICIHR2015Personalized Medicine in Inflammation Network - LOI

Principal investigators: Inman, Robert D; Boonen, Anna

Keywords: Ankylosing Spondyltis; Immunophenotyping; Personal Medicine; Psoriatic Arthritis; Spondyloarthritis

$20,000

Regulation of immunity by TNFR family members: from mechanisms of viral control to biomarkers of therapeutic outcome

Co-investigatorCIHR2014Foundation Grant

Principal investigators: Watts, Tania H

Keywords: Biomarkers; Cancer; Conditional Knockout Mice; Hiv; Influenza; Lymphocytic Choriomeningitis Virus; Multiparameter Flow Cytometry; Rheumatoid Arthritis; Single Nucleotide Polymorphisms; Tnfr Superfamily

$3,563,275

Novel Biomarkers in ankylosing spondylitis: Implications for pathogenesis and therapeutics

Co-investigatorCIHR2012Operating Grant

Principal investigators: Tsui, Florence W

Keywords: Ankylosing Spondylitis; Diagnostic/Prognostic Markers; Pathogenesis; Therapeutics

$781,760

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2025

Subject: Prospective PhD student: Ankylosing Spondylitis Dear Professor Inman, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada Living Treatment Recommendations for the Management of Axial Spondyloarthritis: Update #1" (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Targeting Exosome-Induced Regulatory T Cell Dysfunction in Ankylosing Spondylitis: A Preclinical Path to Precision Therapy" (2025), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction

Robert Inman

Research

Latest papers

Latest funding

Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada Living Treatment Recommendations for the Management of Axial Spondyloarthritis: Update #1

Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada Living Treatment Recommendations for the Management of Axial Spondyloarthritis

Selective disruption of Traf1/cIAP2 interaction attenuates inflammatory responses and rheumatoid arthritis.

Resilience is associated with cortical gray matter of the antinociceptive pathway in people with chronic pain.

Translating Improvements with Ixekizumab in Clinical Trial Outcomes into Clinical Practice: ASAS40, Pain, Fatigue, and Sleep in Ankylosing Spondylitis.

Axial disease in psoriatic arthritis and ankylosing spondylitis: a critical comparison.

Infection with the Lyme disease pathogen suppresses innate immunity in mice with diet-induced obesity.

Private rare deletions in SEC16A and MAMDC4 may represent novel pathogenic variants in familial axial spondyloarthritis.

Contribution of phosphatidylserine to membrane surface charge and protein targeting during phagosome maturation.

Targeting Exosome-Induced Regulatory T Cell Dysfunction in Ankylosing Spondylitis: A Preclinical Path to Precision Therapy

Dysregulation of Cytotoxic T Cell Exhaustion in Ankylosing Spondylitis

Canadian Training Platform for Trials Leveraging Existing Networks (CAN-TAP-TALENT)

Canadian Training Platform for Trials Leveraging Existing Networks (CAN-TAP-TALENT)

Immune response after COVID-19 vaccination during maintenance therapy in immune-mediated inflammatory diseases: an observational cohort study (IMPACT)

T cell trafficking and specificity in ankylosing spondylitis

Human Immunology Spondyloarthritis Team (HUMISPOT) studying immunopathogenesis, disease heterogeneity and drug discovery in spondyloarthritis

The Canadian-Netherlands Spondyloarthritis Network (CaN SpAN) for Improved Outcomes through Personalized Medicine

Regulation of immunity by TNFR family members: from mechanisms of viral control to biomarkers of therapeutic outcome

Novel Biomarkers in ankylosing spondylitis: Implications for pathogenesis and therapeutics

Frequent collaborators

Nigil Haroon

Lihi Eder

Dianne Mosher

Reza Donald Mirza

Andras Kapus

Jiwon Oh

Dafna Gladman

Vinod Chandran

Gary Sweeney

Michael Glogauer

Proton Rahman

Sergio Grinstein